Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say ...

The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...

The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Rahul Banerjee, MD, FACP, Fred Hutch Cancer Center: Honored for his research on the association between dexamethasone exposure and visually significant cataracts in multiple myeloma patients. Malek ...

Public-health officials, activists, tech executives and others press everyday Americans to let “experts” and “authorities” control decisions that affect all of society. Technology allows ...

Multiple myeloma is a cancer involving plasma ... according to the state health department. Nationwide, the American Cancer Society estimates that about 35,000 people will be diagnosed with ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...

Last week, the American Cancer Society (ACS) released the full list of 245 new and renewed grants that were awarded between August 1 and December 31, 2024. This significant grant slate included 14 new ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

KANSAS CITY, Mo., Jan. 22, 2025 (GLOBE NEWSWIRE) -- MidAmerica Cancer Care (MACC), a trusted name in Kansas City and western Missouri cancer care, is proud to announce it has joined American ...